Computational models for predicting drug responses in cancer research

Abstract The computational prediction of drug responses based on the analysis of multiple types of genome-wide molecular data is vital for accomplishing the promise of precision medicine in oncology. This will benefit cancer patients by matching their tumor characteristics to the most effective therapy available. As larger and more diverse layers of patient-related data become available, further demands for new bioinformatics approaches and expertise will arise. This article reviews key strategies, resources and techniques for the prediction of drug sensitivity in cell lines and patient-derived samples. It discusses major advances and challenges associated with the different model development steps. This review highlights major trends in this area, and will assist researchers in the assessment of recent progress and in the selection of approaches to emerging applications in oncology.

• Publication year

  2016

• Venue

  Briefings Bioinform.

• Publication date

  2016-07-21

• Fields of study

  Biology, Medicine, Computer Science

• Identifiers
  DOI 10.1093/bib/bbw065PMID 27444372PMCID 5862310
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• rcellminer: exploring molecular profiles and drug response of the NCI-60 cell lines in R

  2016cited by this paper
• Systems biology approaches for identifying adverse drug reactions and elucidating their underlying biological mechanisms

  2016cited by this paper
• A survey of current trends in computational drug repositioning

  2016cited by this paper
• Context Sensitive Modeling of Cancer Drug Sensitivity

  2015cited by this paper
• Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers

  2015cited by this paper
• Predicting response to multidrug regimens in cancer patients using cell line experiments and regularised regression models

  2015cited by this paper
• Preclinical mouse cancer models: a maze of opportunities and challenges.

  2015cited by this paper
• AACR Cancer Progress Report 2015

  2015cited by this paper
• Drug sensitivity in cancer cell lines is not tissue-specific

  2015cited by this paper
• The Precision-Recall Plot Is More Informative than the ROC Plot When Evaluating Binary Classifiers on Imbalanced Datasets

  2015cited by this paper
• Tumor-Derived Cell Lines as Molecular Models of Cancer Pharmacogenomics

  2015cited by this paper
• Ten things we have to do to achieve precision medicine

  2015cited by this paper
• Genetics: Big hopes for big data

  2015cited by this paper
• Identification of Prognostic Groups in High-Grade Serous Ovarian Cancer Treated with Platinum-Taxane Chemotherapy.

  2015cited by this paper
• No more hidden solutions in bioinformatics

  2015cited by this paper
• Pharmacogenomic agreement between two cancer cell line data sets

  2015cited by this paper
• Pharmacogenomics in the clinic

  2015cited by this paper
• Health: Make precision medicine work for cancer care

  2015cited by this paper
• Mapping the effects of drugs on the immune system

  2015cited by this paper
• DIGRE: Drug-Induced Genomic Residual Effect Model for Successful Prediction of Multidrug Effects

  2015cited by this paper
• Building the foundation for genomics in precision medicine

  2015cited by this paper
• Machine learning applications in genetics and genomics

  2015cited by this paper
• Cancer: Reshaping the cancer clinic

  2015cited by this paper
• Evaluating the Use of Linear Mixed-Effect Models for Inference of the Concentration-QTc Slope Estimate as a Surrogate for a Biological QTc Model

  2015cited by this paper
• Predicting Anticancer Drug Responses Using a Dual-Layer Integrated Cell Line-Drug Network Model

  2015cited by this paper
• Relating hepatocellular carcinoma tumor samples and cell lines using gene expression data in translational research

  2015cited by this paper
• Improved large-scale prediction of growth inhibition patterns using the NCI60 cancer cell line panel

  2015cited by this paper
• Signaling pathway models as biomarkers: Patient-specific simulations of JNK activity predict the survival of neuroblastoma patients

  2015cited by this paper
• An ecosystem of cancer cell line factories to support a cancer dependency map

  2015cited by this paper
• An Ensemble Based Top Performing Approach for NCI-DREAM Drug Sensitivity Prediction Challenge

  2014cited by this paper
• A community effort to assess and improve drug sensitivity prediction algorithms

  2014cited by this paper
• A p-Median approach for predicting drug response in tumour cells

  2014cited by this paper
• Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines

  2014cited by this paper
• Intratumor heterogeneity alters most effective drugs in designed combinations

  2014cited by this paper
• A community computational challenge to predict the activity of pairs of compounds

  2014cited by this paper
• Gene signatures of drug resistance predict patient survival in colorectal cancer

  2014cited by this paper
• Robust Prediction of Anti-Cancer Drug Sensitivity and Sensitivity-Specific Biomarker

  2014cited by this paper
• Gene Expression Profile Alone Is Inadequate In Predicting Complete Response In Multiple Myeloma

  2014cited by this paper
• Similarity network fusion for aggregating data types on a genomic scale

  2014cited by this paper
• The REST Gene Signature Predicts Drug Sensitivity in Neuroblastoma Cell Lines and Is Significantly Associated with Neuroblastoma Tumor Stage

  2014cited by this paper
• Drug-Diagnostics Co-Development in Oncology

  2014cited by this paper
• In vitro clinical trials: the future of cell-based profiling

  2014cited by this paper
• pRRophetic: An R Package for Prediction of Clinical Chemotherapeutic Response from Tumor Gene Expression Levels

  2014cited by this paper
• Drug susceptibility prediction against a panel of drugs using kernelized Bayesian multitask learning

  2014cited by this paper
• Computational identification of multi-omic correlates of anticancer therapeutic response

  2014cited by this paper
• Cancer cell lines for drug discovery and development.

  2014cited by this paper
• A comprehensive transcriptional portrait of human cancer cell lines

  2014cited by this paper
• Profiles of Basal and Stimulated Receptor Signaling Networks Predict Drug Response in Breast Cancer Lines

  2013cited by this paper
• Cancer Genome Landscapes

  2013cited by this paper
• Addressing genetic tumor heterogeneity through computationally predictive combination therapy.

  2013cited by this paper
• An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules.

  2013cited by this paper
• Inconsistency in large pharmacogenomic studies

  2013cited by this paper
• Prediction Errors in Learning Drug Response from Gene Expression Data – Influence of Labeling, Sample Size, and Machine Learning Algorithm

  2013cited by this paper
• Modeling RAS Phenotype in Colorectal Cancer Uncovers Novel Molecular Traits of RAS Dependency and Improves Prediction of Response to Targeted Agents in Patients

  2013cited by this paper
• Prediction of kinase inhibitor response using activity profiling, in vitro screening, and elastic net regression

  2013cited by this paper
• Modeling precision treatment of breast cancer

  2013cited by this paper
• The clinical relevance of cancer cell lines.

  2013cited by this paper
• Evaluating cell lines as tumour models by comparison of genomic profiles

  2013cited by this paper
• Comprehensive Biomarker Analysis and Final Efficacy Results of Sorafenib in the BATTLE Trial

  2013cited by this paper
• The Stream Algorithm: Computationally Efficient Ridge-Regression via Bayesian Model Averaging, and Applications to Pharmacogenomic Prediction of Cancer Cell Line Sensitivity

  2013cited by this paper
• Global proteome analysis of the NCI-60 cell line panel.

  2013cited by this paper
• Systematic Assessment of Analytical Methods for Drug Sensitivity Prediction from Cancer Cell Line Data

  2013cited by this paper
• Drug-Diagnostics Co-Development in Oncology

  2013cited by this paper
• The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity

  2012cited by this paper
• Patient-derived tumour xenografts as models for oncology drug development

  2012cited by this paper
• Abstract 3499: CD56 targeted chimeric antigen receptors for immunotherapy of multiple myeloma

  2012cited by this paper
• Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells

  2012cited by this paper
• Caveats and pitfalls of ROC analysis in clinical microarray research (and how to avoid them)

  2012cited by this paper
• CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set.

  2012cited by this paper
• Machine Learning Prediction of Cancer Cell Sensitivity to Drugs Based on Genomic and Chemical Properties

  2012cited by this paper
• Systematic identification of genomic markers of drug sensitivity in cancer cells

  2012cited by this paper
• An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance

  2012cited by this paper
• Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance

  2011cited by this paper
• Advances in the preclinical testing of cancer therapeutic hypotheses

  2011cited by this paper
• Integrated Genomic Analyses of Ovarian Carcinoma

  2011cited by this paper
• Topology based data analysis identifies a subgroup of breast cancers with a unique mutational profile and excellent survival

  2011cited by this paper
• On Over-fitting in Model Selection and Subsequent Selection Bias in Performance Evaluation

  2010cited by this paper
• Development of biomarker classifiers from high-dimensional data

  2009cited by this paper
• The NCI60 human tumour cell line anticancer drug screen

  2006cited by this paper
• Bias in error estimation when using cross-validation for model selection

  2006cited by this paper
• Assessing the accuracy of prediction algorithms for classification: an overview

  2000cited by this paper

• DeepKGI: Cross-layer graph fusion and interpretable key gene identification for cancer drug response prediction

  2026cites this paper
• DisSNPNet: Predicting disease-associated single-nucleotide polymorphisms using linkage disequilibrium, disease similarity, and 1000 Genomes Project datasets with evidence-based validation

  2026cites this paper
• GenReP: An Ensemble Model for Predicting TP53 in Response to Pharmaceutical Compounds.

  2026cites this paper
• Comparables XAI: Faithful Example-based AI Explanations with Counterfactual Trace Adjustments

  2026cites this paper
• Predicting temozolomide response in low-grade glioma patients with large-scale machine learning

  2025cites this paper
• Modeling Glioblastoma for Translation: Strengths and Pitfalls of Preclinical Studies

  2025cites this paper
• Beyond single biomarkers: multi-omics strategies to predict immunotherapy outcomes in blood cancers

  2025cites this paper
• From In Silico to In Vitro: A Comprehensive Guide to Validating Bioinformatics Findings

  2025cites this paper
• Advanced Technologies for Large Scale Supply of Marine Drugs

  2025cites this paper
• GraphPINE: Graph Importance propagation for interpretable drug response prediction

  2025cites this paper
• A Novel Approach in Automatic Identification of Cancer Cell Drug Sensitivity Utilizing Regression-Based Ensemble Convolution Neural Networks

  2025cites this paper
• The impact of compression and confinement in tumor growth and progression: emerging concepts in cancer mechanobiology

  2025cites this paper
• DTLCDR: A target-based multimodal fusion deep learning framework for cancer drug response prediction

  2025cites this paper
• A NOVEL REGRESSION-BASED ENSEMBLE CONVOLUTIONAL NEURAL NETWORK APPROACH FOR AUTOMATIC CANCER CELL DRUG SENSITIVITY PREDICTION

  2025cites this paper
• Computer-aided drug discovery strategies for novel therapeutics for prostate cancer leveraging next-generation sequencing data

  2024cites this paper
• drGT: Attention-Guided Gene Assessment of Drug Response Utilizing a Drug-Cell-Gene Heterogeneous Network

  2024cites this paper
• Bactericidal, anti-hemolytic, and anticancerous activities of phytofabricated silver nanoparticles of glycine max seeds

  2024cites this paper
• An integrated framework for prognosis prediction and drug response modeling in colorectal liver metastasis drug discovery

  2024cites this paper
• MCMVDRP: a multi-channel multi-view deep learning framework for cancer drug response prediction

  2024cites this paper
• Unraveling the complexities of colorectal cancer and its promising therapies - An updated review.

  2024cites this paper
• DeepDRA: Drug repurposing using multi-omics data integration with autoencoders

  2024cites this paper
• DRPO: A deep learning technique for drug response prediction in oncology cell lines

  2024cites this paper
• Debiased inference for heterogeneous subpopulations in a high-dimensional logistic regression model

  2023cites this paper
• Design and Self Assembly of Tri-Terpene Peptide Conjugates and Their Interactions with EGFR and EGFR Mutant Receptors: An In Silico and In Vitro Study

  2023cites this paper
• Translational Bioinformatics Applied to the Study of Complex Diseases

  2023cites this paper
• Leveraging synthetic lethality to uncover potential therapeutic target in gastric cancer

  2023cites this paper
• Computer-aided drug design in anti-cancer drug discovery: What have we learnt and what is the way forward? ?

  2023cites this paper
• NeuPD—A Neural Network-Based Approach to Predict Antineoplastic Drug Response

  2023cites this paper
• Cancer drug sensitivity prediction from routine histology images

  2023cites this paper
• Rise of Deep Learning Clinical Applications and Challenges in Omics Data: A Systematic Review

  2023cites this paper
• A systematic review of computational approaches to understand cancer biology for informed drug repurposing

  2023cites this paper
• Exploiting convergent phenotypes to derive a pan-cancer cisplatin response gene expression signature

  2023cites this paper
• Tensor completion with noisy side information

  2023cites this paper
• NSUN2 Promotes Tumor Progression and Regulates Immune Infiltration in Nasopharyngeal Carcinoma

  2022cites this paper
• Biomarker discovery using contaminated mixed tumor samples

  2022cites this paper
• MR.DRP: A Parameter Adaptive Machine Learning Framework for Drug Response Prediction

  2022cites this paper
• Deep learning methods for drug response prediction in cancer: Predominant and emerging trends

  2022cites this paper
• NeRD: a multichannel neural network to predict cellular response of drugs by integrating multidimensional data

  2022cites this paper
• Evolution of precision oncology-guided treatment paradigms.

  2022cites this paper
• Molecular pathways enhance drug response prediction using transfer learning from cell lines to tumors and patient-derived xenografts

  2022cites this paper
• Anti-breast cancer drugs targeting cell-surface glucose-regulated protein 78: a drug repositioning in silico study

  2022cites this paper
• Application of machine learning to predict the yield of alginate lyase solid-state fermentation by Cunninghamella echinulata: artificial neural networks and support vector machine

  2022cites this paper
• Deep learning prediction of chemical-induced dose-dependent and context-specific multiplex phenotype responses and its application to personalized alzheimer’s disease drug repurposing

  2022cites this paper
• Exploring synthetic lethal network for the precision treatment of clear cell renal cell carcinoma

  2022cites this paper
• Liquid biopsies for early diagnosis of brain tumours: in silico mathematical biomarker modelling

  2022cites this paper
• TCR: A Transformer Based Deep Network for Predicting Cancer Drugs Response

  2022cites this paper
• Growth‐rate model predicts in vivo tumor response from in vitro data

  2022cites this paper
• Deep reinforcement learning for personalized treatment recommendation

  2022cites this paper
• A generative recommender system with GMM prior for cancer drug generation and sensitivity prediction

  2022cites this paper
• Exploiting convergent evolution to derive a pan-cancer cisplatin response gene expression signature

  2022cites this paper
• Dissecting the Genome for Drug Response Prediction.

  2022cites this paper
• Automatic identification of drug sensitivity of cancer cell with novel regression-based ensemble convolution neural network model

  2022cites this paper
• Pan-Cancer Prediction of Cell-Line Drug Sensitivity Using Network-Based Methods

  2022cites this paper
• SynPathy: Predicting Drug Synergy through Drug-Associated Pathways Using Deep Learning.

  2022cites this paper
• The Immune Signatures data resource, a compendium of systems vaccinology datasets

  2022cites this paper
• Exploiting Synthetic Lethal Network for Precision Treatment of Clear Cell Renal Cell Carcinoma

  2021cites this paper
• Mixed-pooling-dropout for convolutional neural network regularization

  2021cites this paper
• Graph Transformer for drug response prediction

  2021cites this paper
• Exploiting convergent evolution to derive a pan-cancer cisplatin sensitivity gene expression signature

  2021cites this paper
• Predictive Modeling of Multiplex Chemical Phenomics for Novel Cells and Patients: Applied to Personalized Alzheimer’s Disease Drug Repurposing

  2021cites this paper
• Predicting Cancer Drug Response In Vivo by Learning an Optimal Feature Selection of Tumour Molecular Profiles

  2021cites this paper
• Research on Drug Response Prediction Model Based on Big Data

  2021cites this paper
• A mathematical investigation into the uptake kinetics of nanoparticles in vitro

  2021cites this paper
• How much can deep learning improve prediction of the responses to drugs in cancer cell lines?

  2021cites this paper
• Phenocopying Glioblastoma: A Review

  2021cites this paper
• oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data

  2021cites this paper
• Mapping the landscape of synthetic lethal interactions in liver cancer

  2021cites this paper
• Predicting anti-cancer drug response by finding optimal subset of drugs

  2021cites this paper
• The effect of dimethyl sulfoxide on Corynebacterium pseudotuberculosis biofilm: An in silico prediction and experimental validation

  2021cites this paper
• Computational modeling of cell signaling and mutations in pancreatic cancer

  2021cites this paper
• Mouse models of glioblastoma for the evaluation of novel therapeutic strategies

  2021cites this paper
• kESVR: An Ensemble Model for Drug Response Prediction in Precision Medicine Using Cancer Cell Lines Gene Expression

  2021cites this paper
• Artificial intelligence in early drug discovery enabling precision medicine

  2021cites this paper
• Predicting breast cancer drug response using a multiple-layer cell line drug response network model

  2021influential citation
• Pharmacogenetics and personalized medicine

  2021cites this paper
• RePhine: An Integrative Method for Identification of Drug Response-related Transcriptional Regulators

  2021cites this paper
• DIVERSE: Bayesian Data IntegratiVE Learning for Precise Drug ResponSE Prediction

  2021cites this paper
• Differential Splicing of Skipped Exons Predicts Drug Response in Cancer Cell Lines

  2021cites this paper
• Models of Cancer Drug Discovery and Response to Therapy

  2021cites this paper
• Facilitating Drug Discovery in Breast Cancer by Virtually Screening Patients Using In Vitro Drug Response Modeling

  2021cites this paper
• The Aurora kinase/β-catenin axis contributes to dexamethasone resistance in leukemia

  2021cites this paper
• Interpretable deep recommender system model for prediction of kinase inhibitor efficacy across cancer cell lines

  2021cites this paper
• A stability-driven protocol for drug response interpretable prediction (staDRIP)

  2020cites this paper
• Dr. Query: A Predictive Mobile-Based Healthcare Tool for Querying Drug

  2020cites this paper
• RefDNN: a reference drug based neural network for more accurate prediction of anticancer drug resistance

  2020influential citation
• Graph convolutional networks for drug response prediction

  2020cites this paper
• Applications of personalised signalling network models in precision oncology.

  2020cites this paper
• G2M Cell Cycle Pathway Score as a Prognostic Biomarker of Metastasis in Estrogen Receptor (ER)-Positive Breast Cancer

  2020cites this paper
• Predicting treatment effects in unipolar depression: A meta-review.

  2020cites this paper
• Personalized logical models to investigate cancer response to BRAF treatments in melanomas and colorectal cancers

  2020cites this paper
• Machine learning approaches to drug response prediction: challenges and recent progress

  2020cites this paper
• Identification of four hub genes as promising biomarkers to evaluate the prognosis of ovarian cancer in silico

  2020cites this paper
• RNCE: network integration with reciprocal neighbors contextual encoding for multi-modal drug community study on cancer targets

  2020cites this paper
• Concise Polygenic Models for Cancer-Specific Identification of Drug-Sensitive Tumors from Their Multi-Omics Profiles

  2020cites this paper
• Predicting tumor response to drugs based on gene-expression biomarkers of sensitivity learned from cancer cell lines

  2020cites this paper
• The E2F Pathway Score as a Predictive Biomarker of Response to Neoadjuvant Therapy in ER+/HER2− Breast Cancer

  2020cites this paper
• Q-Rank: Reinforcement Learning for Recommending Algorithms to Predict Drug Sensitivity to Cancer Therapy

  2020cites this paper
• An Improved Anticancer Drug-Response Prediction Based on an Ensemble Method Integrating Matrix Completion and Ridge Regression

  2020cites this paper
• Predicting drug sensitivity of cancer cells based on DNA methylation levels

  2020cites this paper
• ADRML: anticancer drug response prediction using manifold learning

  2020cites this paper